“…For example, P-gp and BCRP (Breast Cancer Resistance Protein), found on the luminal surfaces of cells in the gut, modulate oral bioavailability of drug, and are, therefore, key determinants of ADME properties. 75,82 For example, increased expression of P-gp in cancer cells confers resistance to various chemotherapeutic agents. 3DEM structures, beginning with the complex of P-gp with cyclic peptide inhibitors (PDB 3g61), 83 are revealing the mechanism(s) of action of these transporters and modes of targeted inhibition.…”